To squeeze or not to squeeze. The ARISE-FLUIDS trial
This review summarizes the ARISE-FLUIDS trial, which directly compared two distinct resuscitation strategies in septic shock patients presenting to the emergency department. Specifically, it pitted an early vasopressor approach combined with restricted fluid administration against a strategy involving higher initial fluid volumes followed by later vasopressor initiation. The primary finding reported was that neither of these management paradigms demonstrated superiority regarding the key outcome of days alive at day 90. This lack of difference suggests that current resuscitation protocols, which often involve aggressive early fluid loading alongside or instead of immediate pressor support, may not be providing a measurable survival benefit over alternative approaches.
This review summarizes the ARISE-FLUIDS trial, which directly compared two distinct resuscitation strategies in septic shock patients presenting to the emergency department. Specifically, it pitted an early vasopressor approach combined with restricted fluid administration against a strategy involving higher initial fluid volumes followed by later vasopressor initiation. The primary finding reported was that neither of these management paradigms demonstrated superiority regarding the key outcome of days alive at day 90. This lack of difference suggests that current resuscitation protocols, which often involve aggressive early fluid loading alongside or instead of immediate pressor support, may not be providing a measurable survival benefit over alternative approaches.
Show moreShow less
The ARISE-FLUIDS data suggest we shouldn't automatically default to one specific patternāearly vasopressors with restricted fluids versus higher initial volumes followed by later pressors. Given the non-inferiority findings for both arms regarding day 90 survival, it underscores that aggressive fluid resuscitation alone or early vasopressor use in isolation may not be the defining factor; a balanced approach tailored to ongoing hemodynamic goals is warranted.